References for: LACDR-DDS-CTDS
Full identifier: http://purl.org/np/RAdcjjIm7IPqDx73bG45CqnDcWPPhnYQ6cs1d7OSGZGik#LACDR-DDS-CTDS
Nanopublication | Part | Subject | Predicate | Object | Published By | Published On |
---|---|---|---|---|---|---|
links a nanopublication to its assertion
http://www.nanopub.org/nschema#hasAssertion
assertion
|
LACDR-DDS-CTDS
|
(unknown)
|
2023-07-13T21:28:24.000Z
|
|||
links a nanopublication to its assertion
http://www.nanopub.org/nschema#hasAssertion
assertion
|
LACDR-DDS-CTDS
|
LACDR DDS CTDS | Cancer Therapeutics and Drug Safety, Division of Drug Discovery & Safety, LACDR, Leiden University
|
(unknown)
|
2023-07-13T21:28:24.000Z
|
||
links a nanopublication to its assertion
http://www.nanopub.org/nschema#hasAssertion
assertion
|
LACDR-DDS-CTDS
|
In the Cancer Therapeutics and Drug Safety research group at the LACDR, headed by prof. dr. Bob van de Water, cell signaling programs that underlie adverse drug reactions as well as cancer development and progression are unraveled.
|
(unknown)
|
2023-07-13T21:28:24.000Z
|
||
links a nanopublication to its assertion
http://www.nanopub.org/nschema#hasAssertion
assertion
|
LACDR-DDS-CTDS
|
(unknown)
|
2023-07-13T21:28:24.000Z
|
|||
links a nanopublication to its assertion
http://www.nanopub.org/nschema#hasAssertion
assertion
|
LACDR-DDS-CTDS
|
(unknown)
|
2023-07-13T21:28:24.000Z
|
|||
links a nanopublication to its assertion
http://www.nanopub.org/nschema#hasAssertion
assertion
|
LACDR-DDS-CTDS
|
(unknown)
|
2023-07-13T21:28:24.000Z
|
|||
links a nanopublication to its pubinfo
http://www.nanopub.org/nschema#hasPublicationInfo
pubinfo
|
LACDR-DDS-CTDS
|
(unknown)
|
2023-07-13T21:28:24.000Z
|